Lota S. Zoth

Former Chief Financial Officer & Senior Vice President at MedImmune LLC

Lota S. Zoth

Lota S. Zoth

Former Chief Financial Officer & Senior Vice President at MedImmune LLC

Overview
Career Highlights

MedImmune LLC
Medimmune, Inc.

RelSci Relationships

7826

Number of Boards

10

Birthday

1960

Age

60

Number of Awards

1

Relationships
RelSci Relationships are individuals Lota S. Zoth likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Operating Officer & Executive Vice President at Inovio Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Zymeworks, Inc.

Relationship likelihood: Strong

Managing Director, Healthcare Ventures at Ziff Capital Partners

Relationship likelihood: Strong

Chief Executive Officer at Circassia Ltd.

Relationship likelihood: Strong

Co-Founder at Circassia Group Plc

Relationship likelihood: Strong

Former Co-Founder, Chief Executive Officer & Director at Spark Therapeutics, Inc.

Relationship likelihood: Strong

Former Director-Center for Cellular at The Children's Hospital of Philadelphia

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Xeris Pharmaceuticals, Inc.

Relationship likelihood: Strong

Head at German Equtities

Relationship likelihood: Strong

Venture Advisor at New Enterprise Associates

Relationship likelihood: Strong

Paths to Lota S. Zoth
Potential Connections via
Relationship Science
You
Lota S. Zoth
Former Chief Financial Officer & Senior Vice President at MedImmune LLC
Education
B.B.A. in Accounting

Texas Tech University, often referred to as Texas Tech, or TTU, is a public research university in Lubbock, Texas, United States. Established on February 10, 1923, and originally known as Texas Technological College, it is the leading institution of the Texas Tech University System and has the seventh-largest student body in the state of Texas. It is the only school in Texas to house an undergraduate institution, law school, and medical school at the same location. The university offers degrees in more than 150 courses of study through 13 colleges and hosts 60 research centers and institutes. Texas Tech University has awarded over 200,000 degrees since 1927, including over 40,000 graduate and professional degrees.

Career History
Corporate Controller & Chief Accounting Officer
Prior

Marriott International, Inc. engages in the operation and franchise of hotel, residential, and timeshare properties. It operates through the following business segments: North American Full-Service, North American Limited-Service, Asia Pacific, and Other International. The North American Full-Service segment includes luxury and premium brands located in the U.S. and Canada. The North American Limited-Service segment comprises select properties located in the U.S. and Canada. The Asia Pacific segment focuses in all brand tiers in Asia Pacific region. The Other International segment represents its Caribbean and Latin America, Europe, and Middle East and Africa properties. The company was founded by J. Wiliard Marriot and Alice Sheets Marriott in 1927 and is headquartered in Bethesda, MD.

Chief Financial Officer & Senior Vice President
2002 - 2007

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Vice President, Corporate Controller & Chief Accounting Officer
Prior

PepsiCo, Inc. engages in the manufacture, marketing, distribution and sale of beverages, food, and snacks. It is a food and beverage company with a complementary portfolio of brands, including Frito-Lay, Gatorade, Pepsi-Cola, Quaker, and Tropicana. It operates through the following business segments: Frito-Lay North America; Quaker Foods North America; North America Beverages; Latin America; Europe Sub-Saharan Africa; and Asia, Middle East, and North Africa. The Frito-Lay North America segment markets, distributes, and sells snack foods under the Lay's, Doritos, Cheetos, Tostitos, Fritos, Ruffles, and Santitas brands. The Quaker Foods North America segment includes cereals, rice, and pasta under the Quaker, Aunt Jemima, Quaker Chewy, Cap'n Crunch, Life, and Rice-A-Roni brands. The North America Beverages segment consists of beverage concentrates, fountain syrups, and finished goods under various beverage brands such as Pepsi, Gatorade, Mountain Dew, Diet Pepsi, Aquafina, Diet Mountain Dew, Tropicana Pure Premium, Sierra Mist, and Mug. The Latin America segment covers beverage, food, and snack businesses in Latin America region. The Europe Sub-Saharan Africa segment comprises of beverage, food, and snack goods in Europe and Sub-Saharan Africa regions. The Asia, Middle East, and North Africa segment offers snack food products under the Lay's, Kurkure, Chipsy, Doritos, Cheetos, and Crunchy brands. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

Boards & Committees
Member, Board of Directors
2020 - Current

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.

Independent Director
2019 - Current

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Chair, Board of Directors
2016 - Current

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Chairman
2011 - 2018

Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lota S. Zoth. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lota S. Zoth's profile does not indicate a business or promotional relationship of any kind between RelSci and Lota S. Zoth.